Position in TWST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$235,595
-$192,470 QoQ
Shares Held
2,290
-84.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#241
of 334 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $6,325,147 across 7 Diagnostics & Research names. TWST ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MTD |
Mettler Toledo International Inc/
|
2,021 | $2,581,847 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,316 | $2,163,869 | |
| 3 | GH |
Guardant Health, Inc.
|
3,104 | $465,693 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,987 | $383,928 | |
| 5 | NTRA |
Natera, Inc.
|
1,338 | $363,200 | |
| 6 | TWST |
Twist Bioscience Corp
This page
|
2,290 | $235,595 | |
| 7 | MYGN |
Myriad Genetics Inc
|
22,945 | $131,015 |
All Filings in TWST
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,595 | 2,290 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $428,065 | 15,212 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $296,292 | 6,376 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $408,291 | 9,037 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $242,063 | 4,912 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $360,357 | 10,503 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $243,570 | 6,608 | Shares | Sole | 2024-02-09 | |
| 2021-12-31 | $225,204 | 2,910 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $2,981,062 | 24,068 | Shares | Sole | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||